Results from Innovation Activities Highlighted
- Market-launched 33 new drugs approved by Korean regulatory agency(MFDS)
- 15 IND-approved(by US FDA, EMA) new drug candidates
- 200 or so out-licenced(to 30 countries) new drug candidates & technologies
- 300 or so finished drugs & APIs already launched in overseas market including US and EU
- 8 Overseas Regulators Approved & Market Launched New Drugs already launched in U.S. E.U etc.
- 1,000 or so leads or druggable candidates existing in Korean pharmas' labs etc
- 124 to be Commercialized in the Global Market by 2014~2016
- Considering the Success Possibility, 31 of New Drugs Expected by 2020
본문 상단으로 이동
